TAS2R18P and Anophthalmia: This variant was judged to be pathogenic by application of the following criteria: PVS1 (predicted loss of function allele), PS2 (de novo, see below), PS4 (previously reported in several individuals with microphthalmia or anophthalmia) and PM2 (not found in gnomAD) (12,13).